MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: A multicenter, randomized, placebo-controlled phase IIb study

Abraham Adunsky*, Julie Chandler, Norman Heyden, Jeannine Lutkiewicz, Boyd B. Scott, Yuliya Berd, Nancy Liu, Dimitris A. Papanicolaou

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: A multicenter, randomized, placebo-controlled phase IIb study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences